logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回期刊详情
B

blood and lymphatic cancer: targets and therapy

IF
论文数14
被引数
期刊论文 21
发表时间
delete
Metabolic Subtypes Predict Treatment Response in Acute Myeloid Leukemia: A Pilot Study代谢亚型预测急性髓系白血病的治疗反应：一项试点研究
deleteblood and lymphatic cancer: targets and therapy
IF0
delete2026-06-16
delete0
deleteOAAI
deleteChangjian Yan; Yan Huang; Qing Cai; Xiang Li; Qinwen Yang; Gang Feng; Huilin Yang; Yanxin Chen; Jianda Hu
delete分享
delete收藏
A Risk Model Using Refined Disease Risk Index and 1-Month NK-Cell Count for Relapse in Children and Adults with T-ALL/LBL After Myeloablative Umbilical Cord Blood Transplantation使用精炼疾病风险指数和1个月NK细胞计数预测骨髓清除性脐带血移植后儿童及成人T-ALL/LBL复发的风险模型
deleteblood and lymphatic cancer: targets and therapy
IF0
delete2026-05-22
delete0
deleteOAAI
deleteNa Zhao; Rong Chi; Kaidi Song; Yue Wu; Bingbing Yan; Dongyao Wang; Baolin Tang; Xiaoyu Zhu
delete分享
delete收藏
Short-Term Longitudinal Analysis of Gut Microbiota Dynamics During Anti-CD19 CAR-T Cell Therapy in Diffuse Large B-Cell Lymphoma Patients弥漫大B细胞淋巴瘤患者抗CD19 CAR-T细胞治疗期间肠道微生物群动态的短期纵向分析
deleteblood and lymphatic cancer: targets and therapy
IF0
delete2026-05-01
delete0
deleteOAAI
deleteZiyuan Shen; Xing Xing; Kang Rong; Ziyang Geng; Ning Yang; Linyan Xu; Hongfeng Ge; Wei Sang
delete分享
delete收藏
Poor Outcome of Pediatric Patients with Acute Lymphoblastic Leukemia Harboring Low P16 Deletion Ratio: A Post-Hoc Analysis from a Prospective Cohort携带低p16缺失比率的急性淋巴细胞白血病儿科患者预后不良：一项前瞻性队列研究的回顾性分析
deleteblood and lymphatic cancer: targets and therapy
IF0
delete2026-04-30
delete0
deleteOAAI
deleteKun-Yin Qiu; Xiong-Yu Liao; Hai-Lei Chen; Hong Zheng; Jian-Pei Fang; Dun-Hua Zhou
delete分享
delete收藏
Defining High-Risk Disease Biology in Multiple Myeloma: A Narrative Review界定多发性骨髓瘤的高风险疾病生物学：一篇叙述性综述
deleteblood and lymphatic cancer: targets and therapy
IF0
delete2026-04-27
delete0
deleteOAAI
deleteMohammad Aljumaa; Hasan Hamam Refai; Yogesh Chawla; Wilson I Gonsalves
delete分享
delete收藏
Enzymatic Laccase Nanoreactors Induce Apoptosis in MOLT-4-ALL Cells and Activate Prodrugs in a Synergetic Effect酶促漆酶纳米反应器通过协同效应诱导MOLT-4-ALL细胞凋亡并激活前药
deleteblood and lymphatic cancer: targets and therapy
IF0
delete2026-04-27
delete0
deleteOAAI
deleteCarlos A Medrano-Villagómez; Elizabeth Loredo-García; Jahaziel Gasperin-Bulbarela; Rafael Vazquez-Duhalt
delete分享
delete收藏
Prognostic Value of the Aggregate Inflammation Systemic Index (AISI) in Patients with Diffuse Large B-Cell Lymphoma: A Multicenter Retrospective Study弥漫性大B细胞淋巴瘤患者中聚合炎症全身指数（AISI）的预后价值：一项多中心回顾性研究
deleteblood and lymphatic cancer: targets and therapy
IF0
delete2026-03-31
delete0
deleteOAAI
deleteXicheng Chen; Linyu Huang; Qiming Zhang; Xing Xing; Shuo Zhang; Chunling Wang; Ling Wang; Ziyuan Shen; Wei Sang; On behalf of the Huaihai Lymphoma Working Group
delete分享
delete收藏
Crosstalk Between FOXN3 and E2F5 Reveals a Novel Tumor Suppressive Pathway in Acute Myeloid Leukemia via MAPK Signaling: Implications for Potential Future Targeted TherapyFOXN3与E2F5之间的串扰揭示了通过MAPK信号传导在急性髓系白血病中的一种新型肿瘤抑制通路：对未来潜在靶向治疗的启示
deleteblood and lymphatic cancer: targets and therapy
IF0
delete2026-03-24
delete0
deleteOAAI
deleteJinjing Zhang; Qiao Jiang; Tong Liu; Hong Li; Ying Liang; Xianglan Lu; Hui Pang; Shibo Li; Yan Li; Rui Zhang
delete分享
delete收藏
Health Disparities in Acute Myeloid Leukemia Patients Undergoing Treatment with Tyrosine Kinase Inhibitor (TKI) Therapy Targeting FLT3; IDH1; or IDH2酪氨酸激酶抑制剂（TKI）靶向 FLT3、IDH1 或 IDH2 治疗的急性髓系白血病患者的健康差异
deleteblood and lymphatic cancer: targets and therapy
IF0
delete2026-03-12
delete0
deleteOAAI
deleteManuel R Espinoza-Gutarra; Brooke A Jarrett; Xiaoliang Wang; Anosheh Afghahi; Sejong Bae
delete分享
delete收藏
Construction and Validation of an N7-Methylguanosine–Related Prognostic Model for Acute Myeloid LeukemiaN7-甲基鸟苷相关急性髓系白血病预后模型的构建与验证
deleteblood and lymphatic cancer: targets and therapy
IF0
delete2026-03-11
delete0
deleteOAAI
deleteLina Wang, Ming Li, Yaming Xi
delete分享
delete收藏
Association Between Petroleum Compounds Exposure and Risk of Childhood Leukemia: A Systematic Review石油化合物暴露与儿童白血病风险之间的关联：一项系统综述
deleteblood and lymphatic cancer: targets and therapy
IF0
delete2026-02-11
delete0
deleteOAAI
deleteHossam Mohamed Hassan Soliman; Wesal Youssef Hassan; Marwa Mostafa; Mohamed Khamis Gomaa; Mohamed Hossam Soliman Jnr; Mohamed Fakhry Hussein
delete分享
delete收藏
Natural Killer/T-Cell Lymphoma-Associated Hemophagocytic lymphohistiocytosis—a Rare and Dangerous Disease自然杀伤/T细胞淋巴瘤相关的噬血细胞性淋巴组织细胞增生症-一种罕见且危险的疾病
deleteblood and lymphatic cancer: targets and therapy
IF0
delete2026-01-27
delete0
deleteOAAI
deleteGuangqiang Meng; Manzhi Wang; Congcong Sun; Gege Feng; Jing Ren; Saran Feng; Yan Wang
delete分享
delete收藏
Safety and Efficacy of Flumatinib in Patients with Chronic Phase Chronic Myeloid Leukemia: A Real-Life Cohort Observational Study氟马替尼治疗慢性粒细胞白血病慢性期患者的安全性和有效性: 一项真实队列观察性研究
deleteblood and lymphatic cancer: targets and therapy
IF0
delete2026-01-22
delete0
deleteOAAI
deleteFang Cheng; Zheng Cui; Qiang Li; Liu Wang; Weiming Li
delete分享
delete收藏
Study on the Role of Neutrophil Extracellular Traps-Based Risk Model and Discriminative Gene LTF in the Prognosis of Acute Myeloid Leukemia and the Regulation of Immune Microenvironment基于中性粒细胞胞外陷阱的风险模型及鉴别基因LTF在急性髓系白血病预后中的作用及对免疫微环境的调控研究
deleteblood and lymphatic cancer: targets and therapy
IF0
delete2026-01-13
delete0
deleteOAAI
deleteYongjian Li; Jingru Zhang; Tingting Liu; Di Zhang; Nana Wang; Xiaomin Liu; Panpan Feng; Juan Zhang; Chunyan Ji; Jingjing Ye
delete分享
delete收藏
Global Patterns; Temporal Trends; and Potential Non-Infectious Risk Factors for Burkitt Lymphoma from 1990 to 2021全球模式、时间趋势及1990年至2021年伯基特淋巴瘤的潜在非感染性危险因素
deleteblood and lymphatic cancer: targets and therapy
IF0
delete2026-01-08
delete0
deleteOAAI
deleteShi-Kai Jin; Jun-Ting Lyu; Zi-Yu Feng; Shu-Qi Zhang; Bin-Yan Lu; Qin-Fu Yan; Jing Li; Jun Du; Zou-Fang Huang
delete分享
delete收藏
Expression and Clinical Significance of BCL2 Interacting Protein 3 Like (BNIP3L) in Serum of Patients with MM血清中BCL2相互作用蛋白3样蛋白（BNIP3L）的表达及其临床意义研究
deleteBlood and Lymphatic Cancer: Targets and Therapy
IF0
delete2025-12-17
delete0
deleteOAAI
deleteYanyu Nong; Zengyi Xiong; Qicai Wang; Mengyuan Gu; Yanting Zheng; Yifan Wang; Jing Wu; Chunni Huang; Zhongqing Li; Jun Luo; Zhian Ling; Ruolin Li
delete分享
delete收藏
LRG1 Drives AML Progression by Disrupting Myeloid Progenitor RegulationLRG1通过破坏髓系祖细胞调控来驱动急性髓系白血病进展
deleteBlood and Lymphatic Cancer: Targets and Therapy
IF0
delete2025-12-17
delete0
deleteOAAI
deleteRongxia Guo; Peng Wu; Shuxin Yao; Fumei Liu
delete分享
delete收藏
Alantolactone Inhibits Double Expression Lymphoma via Dual-Targeted Glycogen Synthase Kinase 3 Beta and B-Cell Lymphoma2Alantolactone 通过双重靶向糖原合成酶激酶3β和 B-细胞淋巴瘤2 抑制双表达淋巴瘤。
deleteBlood and Lymphatic Cancer: Targets and Therapy
IF0
delete2025-12-12
delete0
deleteOAAI
deleteJianhua Chen; Qing Liao; Sha Yang; Jiaojiao Bian; Xianfu Li; Lu Zhao; Dan Wen; Dazhang Bai; Chunlei Yu; Chunyang Zhou; Zhengmin Xu
delete分享
delete收藏
Phase II Trial of an Orelabrutinib-Based Combination Therapy in Newly Diagnosed Primary Central Nervous System Lymphoma奥雷布卢替尼为基础的联合疗法治疗新诊断的原发性中枢神经系统淋巴瘤的II期临床试验
deleteBlood and Lymphatic Cancer: Targets and Therapy
IF0
delete2025-12-06
delete0
deleteOAAI
deleteYajing Zhao; Xinguang Liu; Qiang He; Yafei Yu; Lei Xu; Caifeng Sun; Guoqiang Liu; Liang Wang; Ji Ma
delete分享
delete收藏
Venetoclax Plus Blinatumoma as First Line Therapy for Newly Diagnosed Ph-Negative B-Cell Acute Lymphoblastic Leukemia维奈克拉 plus 布林佐玛作为新诊断的Ph阴性B细胞急性淋巴细胞白血病的初始治疗方案
deleteBlood and Lymphatic Cancer: Targets and Therapy
IF0
delete2025-11-05
delete0
deleteOAAI
deleteYutian Lei; Xiaoli Zhao; Huijun Huang; Limin Duan; Ji Xu; Kourong Miao; Huihui Zhao; Chun Qiao; Ming Hong; Sixuan Qian; Lei Fan; Yu Zhu
delete分享
delete收藏